Totally plc (AIM: TLY)
London
· Delayed Price · Currency is GBP · Price in GBX
9.20
-0.05 (-0.54%)
Jan 17, 2025, 10:45 AM GMT+1
Totally Revenue
Totally had revenue of 41.71M GBP in the half year ending September 30, 2024, a decrease of -40.67%. This brings the company's revenue in the last twelve months to 92.58M, down -23.61% year-over-year. In the fiscal year ending March 31, 2024, Totally had annual revenue of 106.68M, down -21.38%.
Revenue (ttm)
92.58M
Revenue Growth
-23.61%
P/S Ratio
0.19
Revenue / Employee
65.99K
Employees
1,403
Market Cap
17.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 106.68M | -29.02M | -21.38% |
Mar 31, 2023 | 135.70M | 8.32M | 6.53% |
Mar 31, 2022 | 127.37M | 13.66M | 12.02% |
Mar 31, 2021 | 113.71M | 7.76M | 7.33% |
Mar 31, 2020 | 105.95M | 27.94M | 35.82% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |